Anti-Fungal Drugs Flashcards
systemic mycoses can be treated with
amphotericin B(iv)
flucytosine
Azoles(oral)
Cutaneous Candidiasis can be treated by
Nystatin
Azoles
dermatophytic infections can be treated by
Azoles(topical/oral)
Griseofulvin
what are the polyene antifungals
amphotericin B and nystatin
what is the mechanism of aciton of amphotericin B
it interacts hydrophobically with erosterol in the fungal cell membrane, forming a pore
then potassium and other small molecules are lost through the pore, causing death
amphotericin B exhibits what pharmacokinetics
very poor oral absorption
Amphotericin B is sequestered
in tissue membranes very low serum levels
how do you administer amphotericin B
as a freshly prepared suspension liposomal preparations
the half life of amphotericin B is
long 15 days
two types of polyene antifungals which are amphotericin B and nystatin. These drugs have an
amino sugar at one end which is polar but the rest of the molecule is an amphipath. One portion of the amphipathic molecule is unsaturated and therefore likes lipid whereas the other side of the same molecule has a lot of hydroxy groups on it and therefore likes water.
what are the adverse effects
There are some newer liposomal preparations that bypass the problem of having to make a fresh preparation with each use and some of the toxic effects associated with amphotericin B
So instead of doing this by cellular preparation, there are several liposomal formulations where they make an artificial phospholipid membrane in which amphotericin B is embedded (i.e. micelle). However the problem with the liposomal preparations of amphotericin B is that they’re very expensive. So we still mostly give amphotericin B in a deoxycholate type of suspension and that can be delivered to the patient. You only switch over to the liposomal preparation if the patient is showing signs of renal impairment while on the conventional preparation
narrow spectrum of activity; most strains of cryptococcus neoformans
flucytosine
flucytosine is usually used in combination with
amphotericin B
what is the mechanism of Flucytosine
- Flucytosine is fungicidal.
- The fungal cell has a pump. Because of the leaky membrane induced by amphotericin B, flucytosine can gain access into the fungal cell using the pump more readily. We don’t have the pump so flucytosine cannot get into human cells as well but it does get in to some extent.
- Then an enzyme in the fungal cell deaminates flucytosine to remove the amine group so that we wind up with 5-flurouracil. 5-flurouracil is a major component in the treatment of some neoplasms.
- Then in the fungal cell 5-flurouracil is converted into 5-fluro deoxy UMP (5-FdUMP).
- 5-FdUMP is an inhibitor of thymidylate synthase. Therefore 5-FdUMP will prevent the fungal cell from making thymidine.
Because there’s less thymidine in the fungal cell, it will not be able to undergo cell division and you wind up with a significant deleterious effect on the fungi
what are the pharmacokinetics of Flucytosine
it is absorbed well orally
it is dependent upon renal function for elimination
penetrates well into the CNS=70% of serum levels
25% exhibit nausea, vomiting, severe diarrhea and enterocolitis
25% exhibit exlevation of hepatic enzymes
15% exhibit bone marrow depression: anemia, leukopenia, thrombocytopenia
flucytosine